TWiPO #4 ~ Meetings Recap and Immunotherapy for Synovial Cell Sarcoma

2014-02-10

May 08, 2011 In this fourth episode of TWiPO host Dr. Tim Cripe and co-host Dr. Jim Geller discuss updates after two recent meetings and then discuss an exciting paper just published on "Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1" J Clin Oncol. 2011 Mar 1;29(7):917-24. Epub 2011 Jan 31. by Paul Robbins and colleagues at the NCI. 1:23 Conference on oncolytic viruses (see re...

May 08, 2011

In this fourth episode of TWiPO host Dr. Tim Cripe and co-host Dr. Jim Geller discuss updates after two recent meetings and then discuss an exciting paper just published on "Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1" J Clin Oncol. 2011 Mar 1;29(7):917-24. Epub 2011 Jan 31. by Paul Robbins and colleagues at the NCI.

1:23 Conference on oncolytic viruses (see recent http://vimeo.com/20002455 webinar on pediatric trials).

7:28 Conference on DIPG (Diffuse Intrinsic Pontine Glioma) at Cincinnati Children's; discussion on biology, new tumor models, and genetic profiling.

12:50 Discussion on adoptive immunotherapy using tumor-infiltrating lymphocytes in patients with metastatic melanoma and synovial cell sarcoma.

28:28 Listener email questions and answers. (send emails to twipo@solvingkidscancer.org)

Comments (3)